Hepatitis B vaccination in patients with chronic hepatitis C

Journal of Medical Virology

Volumn 59, Issue 4, 1999, Pages 463-468

  Lee, Shou Dong ^a   Chan, Cho Yu ^b   Yu, May Ing ^b   Lu, Rei Hwa ^b   Chang, Full Young ^b   Lo, Kwang Juei ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Chronic hepatitis C; Cytokines; HCV RNA; Hepatitis B vaccine; Immunogenicity

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOGENICITY; VACCINATION;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; CYTOKINES; FEMALE; HEPACIVIRUS; HEPATITIS B CORE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; RNA, VIRAL; VACCINATION;

EID: 0032720065     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199912)59:4<463::AID-JMV7>3.0.CO;2-5     Document Type: Article

References (38)

1. Bradley DW, Marynard JE, McCaustland KA, Murphy BL, Cook EH, Ebert JW. 1983. Non-A, non-B hepatitis in chimpanzees: interference with acute hepatitis C virus and chronic hepatitis B virus infections. J Med Virol 11:207-213.
2. Chan CY, Lee SD, Wu JC, Hwang SJ, Wang YJ, Huang YS, Lo KJ. 1991. Superinfection with hepatitis C virus in patients with symptomatic chronic hepatitis B. Scand J Inf Dis 23:421-424.
3. Chan CY, Lee SD, Tsai YT, Lo KJ. 1992. Long-term follow-up of hepatitis B vaccination in susceptible hospital personnel. J Gastroenterol Hepatol 7:266-269.
4. Chan CY, Lee SD, Hwang SJ, Lu RH, Lu CL, Lo KJ. 1995. Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C. J Inf Dis 171:443-446.
5. Cheng CH, Huang CC, Leu ML, Chiang CY, Wu MS, Lai PC. 1997. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 15:1353-1357.
6. Cohen J. 1994. Vaccines get a new twist. Science 264:503-505.
7. Dienes HP, Purcell RH, Popper H, Ponzetto A. 1990. The significance of infections with two types of viral hepatitis demonstrated by histologic features in chimpanzees. J Hepatol 10:77-84.
8. Fattovich G, Tagger A, Brollo L, Giustina G, Pontisso P, Realdi G, Alberti A, Ruol A. 1991. Hepatitis C virus infection in chronic hepatitis B carriers. J Inf Dis 163:400-402.
9. Feray C, Gigou M, Samuel D, Reyes G, Bernuau J, Reynes M, Bismuth H, Brechot C. 1993. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 104:549-555.
10. Fong TL, DiBisceglie AM, Waggoner JG, Banks SM, Hoofnagle JH. 1991. The significance of antibody to hepatitis C virus in patients with chronic hepatitis B. Hepatology 14:64-67.
11. Grob PJ, Binswanger U, Zaruba K, Joller-Jemelka HI, Schmid M, Hacki W, Blumberg A, Abplanalp A, Herwig W, Iselin H, Descoeudres C. 1983. Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and renal transplant recipients. Antiviral Res 3:43-52.
12. Hollinger F. 1989. Factors influencing the immune response to hepatitis B vaccine, booster dose guidelines, and vaccine protocol recommendations. Am J Med 87:S36-S41.
13. Jacobson IM, Jaffers G, Dienstag JL, Tolkoff-Rubin NE, Cosimi AB, Delmonico F, Watkins E, Hinkle C, O'Rourke S, Russell PS. 1985. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation 39:393-395.
14. Kamel M, El Manialawi M, Miller DF. 1994. Recombinant hepatitis B vaccine immunogenicity in presence of hepatitis C virus seropositivity. Lancet 343:552.
15. Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M, Baumgarten R, Wiese M, Fourneau M, Safary A, Clemens R, Krause DS. 1998. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 27:881-886.
16. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Houghton M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
17. Lee SD, Lo KJ, Tsai YT, Chan CY, Wu TC, Hwang SJ, Chang CP, Huang YS. 1988. Immunogenicity of hepatitis B vaccine in Chinese school children: a comparison of two plasma-derived vaccines. Chinese Med J (Taipei) 42:87-92.
18. Lee SD, Chan CY, Wang YJ, Wu JC, Lai KH, Tsai YT, Lo KJ. 1991. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 13:830-833.
19. Lee SD, Wang YJ, Lin HC, Wu JC, Chan CY. Huang YS, Tsai YT, Lo KJ. 1992. Prevalence of anti-HCV among Chinese patients with acute and chronic liver disease. J Gastroenterol Hepatol 7:113-116.
20. Lee SD, Chan CY, Yu MI, Wang YJ, Lo KJ, Safary A. 1996. Single dose inactivated hepatitis A vaccination schedule for susceptible youngsters. Am J Gastroenterol 91:1360-1362.
21. Lee SD, Chan CY, Yu MI, Wang YJ, Chang FY, Lo KJ, Safary A. 1997. Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease. J Med Virol 52:215-218.
22. Liaw YF, Chu CM, Chang-Chien CS, Wu CS. 1982. Simultaneous acute infections with hepatitis non-A, non-B, and B viruses. Dig Dis Sci 27:72-74.
23. Liaw YF, Lin SM, Sheen IS, Chu CM. 1991. Acute hepatitis C super-infection followed by spontaneous HBeAg and HBsAg seroconversion. Infection 19:250-251.
24. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus. 1995. Hepatology 22:1101-1108.
25. Lo KJ, Lee SD, Tsai YT, Wu TC, Chan CY, Chen GH, Yeh CL. 1988. Long-term immunogenicity and efficacy of hepatitis B vaccine in infants born to HBeAg-positive HBsAg-carrier mothers. Hepatology 8:1647-1650.
26. Lu CL, Chan CY, Hwang SJ, Lu RH, Lee SD. 1995. Efficacy of ursodeoxycholic acid in the treatment of patients with chronic hepatitis C. J Gastroenterol Hepatol 10:432-437.
27. Lu SN, Chue PY, Chen HC, Wu MH, Chen IL, Huang JF, Wang JH, Peng CF, Shih CH, You SL, Lu CF, Chen CJ, Chang WY. 1997. Different viral aetiology of hepatocellular carcinoma between two hepatitis B and C endemic townships in Taiwan. J Gastroenterol Hepatol 12:547-550.
28. Navarro JF, Teruel JL, Mateos ML, Marce R, Ortuno J. 1996. Antibody level after hepatitis B vaccination in hemodialysis patients: influence of hepatitis C virus infection. Am J Nephrol 16:95-97.
29. Ninova D, Krom RA, Wiesner RH. 1995. Hepatic allograft rejection is associated with increased levels of soluble intercellular adhesion molecule-1. Liver Transplant Surg 1:290-295.
30. Pirisi M, Vitulli D, Falleti E, Fabris C, Soardo G, Del Forno M, Bardus P, Gonano F, Bartoli E. 1997. Increased soluble ICAM-1 concentration and impaired delayed-type hypersensitivity skin tests in patients with chronic liver disease. J Clin Pathol 50:50-53.
31. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, Alberti A. 1993. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 105:1529-1533.
32. Sheen IS, Liaw YF, Chu CM, Pao CC. 1992. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during chronic hepatitis B virus infection. J Inf Dis 165:831-834.
33. Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W. 1984. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 311:496-501.
34. Sung JL. 1981. Hepatitis B virus infection and its sequelae in Taiwan. Proc Natl Sci Council ROC 15:385-399.
35. Taketomi A, Takenaka K, Matsumata T, Shimada M, Higashi H, Shirabe K, Itasaka H, Adachi E, Maeda T, Sugimachi K. 1997. Circulating intercellular adhesion molecule-1 in patients with hepatocellular carcinoma before and after hepatic resection. HepatoGastroenterology 44:477-483.
36. Wu JC, Chen CL, Hou MC, Chen TZ, Lee SD, Lo KJ. 1994. Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction. Hepatology 19:836-340.
37. Yoshioka K, Kakumus S, Arao M, Tsutsumi Y, Inoue M. 1989. Tumor necrosis factor production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 10:769-773.
38. Yoshioka K, Kakumus S, Arao M, Tsutsumi Y, Inoue M, Wakita T, Ishikawa T, Mizokami M. 1990. Immunohistochemical studies of intrahepatic tumor necrosis factor in chronic liver disease. J Clin Pathol 43:298-302.